Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy.
Breast Cancer Res Treat
; 201(3): 387-396, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37460683
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2023
Type:
Article
Affiliation country:
United States